IN VIVO MICROSYSTEMS TECHNOLOGIES, LLC
In-vivo study of KSP/QRH heptapeptide dimer for detection of biliary intra-epithelial neoplasia
In-vivo study of KSP/QRH heptapeptide dimer for detection of biliary intra-epithelial neoplasia is a funding opportunity from IN VIVO MICROSYSTEMS TECHNOLOGIES, LLC, up to 1022055, closing August 31, 2027.
Aug 31, 2027
(396d left)Overview
Project Summary In this Direct to Phase 2 SBIR proposal, IVMT, LLC aims to perform a Phase 2 multi-center study to advance the clinical utility of a targeted image contrast agent. This small business start-up has been formed to commercialize highly sensitive cancer-specific imaging agents. A near-infrared (NIR)…